MALVERN, Pa., Sept. 4, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]-therapy-system-300911484.html